A61K 38/2093
Leukaemia inhibitory factor [lif]
Official title: {Leukaemia inhibitory factor [LIF]}
A61K38/2093 (Leukaemia inhibitory factor [lif]) appears on 53 US grants and 71 published applications in this corpus.
Search patents in A61K- Granted patents
- 53
- Published applications
- 71
- Assignees
- 43
- Inventors
- 148
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 4 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 3 |
| 2004 | 0 | 2 |
| 2005 | 0 | 2 |
| 2006 | 2 | 2 |
| 2007 | 1 | 7 |
| 2008 | 0 | 4 |
| 2009 | 1 | 3 |
| 2010 | 2 | 2 |
| 2011 | 0 | 3 |
| 2012 | 3 | 2 |
| 2013 | 0 | 2 |
| 2014 | 0 | 1 |
| 2015 | 8 | 8 |
| 2016 | 2 | 2 |
| 2017 | 4 | 4 |
| 2018 | 1 | 4 |
| 2019 | 5 | 5 |
| 2020 | 3 | 2 |
| 2021 | 4 | 2 |
| 2022 | 1 | 5 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 2 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Targeting peptides for directing adeno-associated viruses (AAVs)16 Jun 2026US 12,653,904 B2California Institute of Technology
- Methods of making chimeric antigen receptor-expressing cells19 May 2026US 12,630,604 B2Novartis AG
- System and method for the production, formulation and use of conditioned media, cultured cells and the factors included therein10 Mar 2026US 12,569,537 B2Rinati Skin, LLC
- Selective recovery19 Mar 2024US 11,932,668 B2California Institute of Technology
- Targeting peptides for directing adeno-associated viruses (AAVs)15 Nov 2022US 11,499,165 B2California Institute of Technology
- System and Method for the Production, Formulation and Use of Conditioned Media, Cultured Cells and the Factors Included Therein26 Mar 2026US 2026/0083818 A1Rinati Skin, LLC
- Tissue regenerative multi-drug cocktail and apparatus for delivery thereof8 Jan 2026US 2026/0007720 A1Trustees of Tufts College
- Novel therapeutic comprising a secretome from mesenchymal stem cells of umbilicord tissue or wharton's jelly5 Jun 2025US 2025/0177455 A1Celligenics Pte. Ltd.
- Neuroprotective compositions and use thereof13 Feb 2025US 2025/0049889 A1NanoNeuron Therapeutics, Inc.
- Targeting peptides for directing adeno-associated viruses (aavs)21 Sep 2023US 2023/0295659 A1California Institute of Technology
Most cited
By later US patents
- Recombinant AAV capsid protein95US 9,585,971 B2California Institute of Technology · 2017
- Use of GnRH agonists to support the luteal phase during infertility treatment58US 7,671,027 B2PregLem SA · 2010
- Method of inducing formation of kidney epithelia from mesenchymal precursors25US 6,423,681 B1The Trustees of Columbia University in the City of New York · 2002
- Hybrid cytokines14US 6,171,824 B2Fred Hutchinson Cancer Research Center · 2001
- Enhanced ocular neuroprotection and neurostimulation14US 7,833,966 B22010